Viatris Inc Logo

Viatris Inc

A global healthcare company distributing branded and generic medicines in over 165 countries.

VTRS | US

Overview

Corporate Details

ISIN(s):
US92556V1061
LEI:
Country:
United States of America
Address:
1000 MYLAN BOULEVARD, 15317 CANONSBURG
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Viatris Inc. is a global healthcare company formed in 2020 through the combination of Mylan and Pfizer's Upjohn business. The company's mission is to empower people worldwide to live healthier by expanding access to medicine. Viatris develops, manufactures, and distributes a diverse portfolio of high-quality medicines, including branded and generic drugs, complex dosage forms, and active pharmaceutical ingredients (APIs). Its products cover a broad range of therapeutic areas, spanning both noncommunicable and infectious diseases. The company aims to bridge the traditional divide between generics and brands, leveraging its global infrastructure to serve patients in over 165 countries and territories.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Viatris Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Viatris Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Viatris Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DONGWHA PHARM.CO.,LTD Logo
Develops, manufactures, and sells a diverse portfolio of healthcare products globally.
South Korea
000020
Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland
DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden
DBP B
DR REDDYS LABORATORIES LTD Logo
Global pharma firm providing affordable generics, APIs, and medicines to patients worldwide.
United States of America
RDY
Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.
South Korea
176750
Dx & Vx Co., Ltd. Logo
Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.
South Korea
180400
DYNAVAX TECHNOLOGIES CORP Logo
Biopharma firm developing novel vaccines, like its adult hepatitis B vaccine, with adjuvant tech.
United States of America
DVAX
Dyne Therapeutics, Inc. Logo
Developing targeted therapies for genetic neuromuscular diseases via its FORCE™ platform.
United States of America
DYN
Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.
South Korea
044960
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom
EAH

Talk to a Data Expert

Have a question? We'll get back to you promptly.